Xenon Pharmaceuticals Inc. Share Price
XENEXenon Pharmaceuticals Inc. Stock Performance
Open $66.06 | Prev. Close $66.09 | Circuit Range N/A |
Day Range $65.78 - $66.83 | Year Range $30.03 - $72.50 | Volume 53,888 |
Average Traded $66.38 |
Xenon Pharmaceuticals Inc. Share Price Chart
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Xenon Pharmaceuticals Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-Jul-26 | $68.33 | $66.05 | -3.21% |
17-Jul-26 | $66.32 | $68.23 | +1.81% |
16-Jul-26 | $67.14 | $67.02 | -1.00% |
15-Jul-26 | $66.92 | $67.70 | +0.59% |
14-Jul-26 | $67.62 | $67.31 | -0.66% |
13-Jul-26 | $67.09 | $67.75 | -1.68% |
10-Jul-26 | $71.03 | $68.91 | -2.94% |